Category: Press Release - Page 74 - Psychedelic Alpha

Read more about the article Mydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member

Mydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member

Post published:February 3, 2022
Post category:Press Release

Read more about the article IntelGenx Receives Third Loan Tranche from atai

IntelGenx Receives Third Loan Tranche from atai

Post published:February 1, 2022
Post category:Press Release

Read more about the article Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ET

Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ET

Post published:February 1, 2022
Post category:Press Release

Psyched Wellness Announces Launch of New Logo, Branding, and Website, Prepares to Release Industry-First Amanita Muscaria Tincture

Post published:February 1, 2022
Post category:Press Release

Numinus Appoints New Bioscience Advisors to Advance IP Development

Post published:February 1, 2022
Post category:Press Release

Read more about the article PharmaTher Granted FDA Orphan Drug Designation for Ketamine to Treat Status Epilepticus

PharmaTher Granted FDA Orphan Drug Designation for Ketamine to Treat Status Epilepticus

Post published:February 1, 2022
Post category:Press Release

Read more about the article Mydecine Submits Pre-Investigational New Drug Briefing Package to the FDA for MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial

Mydecine Submits Pre-Investigational New Drug Briefing Package to the FDA for MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial

Post published:February 1, 2022
Post category:Press Release

Read more about the article Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million

Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million

Post published:February 1, 2022
Post category:Press Release

Read more about the article Small Pharma Reports Fiscal Third Quarter 2021 Highlights

Small Pharma Reports Fiscal Third Quarter 2021 Highlights

Post published:January 31, 2022
Post category:Press Release

Read more about the article Red Light Holland’s Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the Special Access Program

Red Light Holland’s Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the Special Access Program

Post published:January 28, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.